Loading…
Reported covered position: 2021: Paid Intern, Rep. Colin Allred
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WHOLESOME WAVE, INC. via MCDERMOTT+ LLC
2026 · third_quarter · 3T
Efforts related to Produce Prescriptions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WHOLESOME WAVE, INC. via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Source: Senate LDA
| NOOM, INC. |
| 6 |
| 2025–2026 |
| WHOLESOME WAVE, INC. | 4 | 2025–2026 |
| URGENT CARE ASSOCIATION | 2 | 2023 |
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Expansion Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Telehealth Benefit Expansion for Workers Act of 2023
Client: THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) · Firm: MCDERMOTT+ LLC
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts related to Produce Prescriptions.
Efforts related to Produce Prescriptions.
Efforts related to Produce Prescriptions.
Efforts related to Produce Prescriptions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2026 · second_quarter · 2T
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · 2T
issues relating to virtual care services
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2026 · second_quarter · Q2
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDA HEALTH, INC. via MCDERMOTT+ LLC
2026 · second_quarter · 2T
Efforts to protect Medicare coverage of telehealth services and virtual cardio and pulmonary rehabilitation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+ LLC
2026 · second_quarter · 2T
Efforts to protect Medicare coverage of telehealth services and intensive cardiac rehabilitation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WHOLESOME WAVE, INC. via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Efforts related to Produce Prescriptions.
Efforts related to Produce Prescriptions.
Efforts related to Produce Prescriptions.
CARDA HEALTH, INC. via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Efforts to protect Medicare coverage of telehealth services and virtual cardio and pulmonary rehabilitation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Efforts to protect Medicare coverage of telehealth services and intensive cardiac rehabilitation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
issues relating to virtual care services
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+ LLC
2026 · first_quarter · Q1
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WHOLESOME WAVE, INC. via MCDERMOTT+
2025 · fourth_quarter · Q4
Efforts related to Produce Prescriptions.
Efforts related to Produce Prescriptions.
Efforts related to Produce Prescriptions.
CARDA HEALTH, INC. via MCDERMOTT+
2025 · fourth_quarter · Q4
Efforts to protect Medicare coverage of telehealth services and virtual cardio and pulmonary rehabilitation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+
2025 · fourth_quarter · Q4
Efforts to protect Medicare coverage of telehealth services and intensive cardiac rehabilitation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOOM, INC. via MCDERMOTT+
2025 · fourth_quarter · Q4
issues relating to virtual care services
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+
2025 · fourth_quarter · Q4
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+
2025 · fourth_quarter · Q4
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · third_quarter · Q3
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDA HEALTH, INC. via MCDERMOTT+
2025 · third_quarter · Q3
efforts to protect medicare coverage of telehealth services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+
2025 · third_quarter · Q3
efforts to protect medicare coverage of telehealth services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · third_quarter · Q3
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOOM, INC. via MCDERMOTT+
2025 · third_quarter · Q3
issues relating to virtual care services
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+
2025 · third_quarter · Q3
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+
2025 · third_quarter · Q3
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARDA HEALTH, INC. via MCDERMOTT+
2025 · second_quarter · Q2
efforts to protect medicare coverage of telehealth services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+
2025 · second_quarter · Q2
efforts to protect medicare coverage of telehealth services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · second_quarter · Q2
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Q2
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOOM, INC. via MCDERMOTT+
2025 · second_quarter · Q2
issues relating to virtual care services
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+
2025 · second_quarter · Q2
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+
2025 · second_quarter · Q2
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARDA HEALTH, INC. via MCDERMOTT+
2025 · first_quarter · 1A
efforts to protect medicare coverage of telehealth services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+
2025 · first_quarter · Q1
efforts to protect medicare coverage of telehealth services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOOM, INC. via MCDERMOTT+
2025 · first_quarter · Q1
issues relating to virtual care services
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+
2025 · first_quarter · Q1
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+
2025 · first_quarter · Q1
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Efforts relating to expanded access to virtual care services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · first_quarter · Q1
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+
2025 · first_quarter · Q1
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PREVENTIVE MEDICINE RESEARCH INSTITUTE via MCDERMOTT+
2025 · first_quarter · RA
efforts to protect medicare coverage of telehealth services
CARDA HEALTH, INC. via MCDERMOTT+
2025 · first_quarter · RR
efforts to protect medicare coverage of telehealth services
340B HEALTH via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · third_quarter · 3A
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Efforts relating to artificial intelligence, wastewater surveillance, and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+ LLC
2024 · third_quarter · Q3
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
340B HEALTH via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Efforts relating to artificial intelligence, wastewater surveillance, and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+ LLC
2024 · second_quarter · Q2
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
340B HEALTH via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues relating to the 340B Drug Pricing Program.
Issues relating to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Efforts relating to artificial intelligence, wastewater surveillance, and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) via MCDERMOTT+ LLC
2024 · first_quarter · Q1
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
Efforts relating to expanded access to telehealth services, including the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), the Telehealth Expansion Act (H.R. 1843).
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Issues relating to utilization of and access to urgent care centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
URGENT CARE ASSOCIATION via MCDERMOTT+ LLC
2023 · fourth_quarter · RR
Issues relating to utilization of and access to urgent care centers.
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2023 · fourth_quarter · Q4
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
VERILY LIFE SCIENCES LLC via MCDERMOTT+ LLC
2023 · third_quarter · Q3
Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.
Efforts relating to artificial intelligence, wastewater surveillance, and drug and device innovation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2023 · third_quarter · Q3
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS FOR AFFORDABLE DRUGS NOW via MCDERMOTT+ LLC
2023 · third_quarter · RR
Issues related to prescription drug competition and pricing.
Issues related to prescription drug competition and pricing.
Efforts related to Produce Prescriptions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Efforts related to Produce Prescriptions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE